Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion.
The present study describes a new microscopic perifusion technique for detecting momentary alterations in cell volume and shape. The method has been applied for evaluating early signs of cytotoxicity following chemotherapeutic treatments. The effects of estramustine phosphate (EMP) have been evaluated. EMP is a complex between oestradiol-17 beta and the alkylating agent nor-nitrogen mustard and has recently demonstrated a marked cytotoxicity against malignant glioma cells. The results showed a concentration-dependent increase in cell size and a concomitant decrease in shape factor following EMP-treatment of glioma cells. These changes correlated with cytotoxicity evaluated as cell proliferation and cell membrane alterations shown by 86Rb fluxes and ultrastructural visible membrane damage. The colon cancer line HT-29 displayed no reactions at all following EMP treatment. It is suggested that acute alterations in cell morphology and shape display a strong correlation to the cytotoxicity of EMP encountered by traditional cell culture systems. The findings are discussed with respect to cell membrane disturbances caused by EMP and its potential role as an early test of cytotoxicity.
Engström
K G
KG
Department of Oncology, University Hospital, Umeå, Sweden.
Grankvist
K
K
Henriksson
R
R
D002460:Cell Line; D002462:Cell Membrane / Q000648:ultrastructure; D002470:Cell Survival / Q000187:drug effects; D003110:Colonic Neoplasms / Q000648:ultrastructure; D004305:Dose-Response Relationship, Drug; D004961:Estramustine / Q000633:toxicity*; D005910:Glioma / Q000648:ultrastructure; D006652:Histological Techniques; D006801:Humans; D008855:Microscopy, Electron, Scanning; D012414:Rubidium Radioisotopes / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured / Q000187:drug effects*
D012414:Rubidium Radioisotopes; D004961:Estramustine